The Latest Breaking News from HUM

Market experts continue to fear that higher interest rates from the Federal Reserve and the potential for a credit crunch might tip the economy into a recession. Given this backdrop, quality stocks Oracle Corp. (ORCL), Vertex Pharmaceuticals (VRTX), and Humana (HUM) have solid fundamentals that could help them survive a…

High inflation and stock market volatility necessitate adding a defensive layer to your portfolio to save yourself from exhausting all your savings. Hence, one could consider planning their retirement with quality stocks Oracle Corp. (ORCL), CVS Health (CVS), and Humana (HUM), given their strong fundamentals and steady returns. Read on….

The bank failures and the Fed’s monetary tightening have increased the risk of a recession later this year. This is expected to keep the stock market under pressure. Amid this uncertainty, it could be wise to buy and hold fundamentally strong stocks Oracle (ORCL), CVS Health (CVS), and Humana (HUM)…

The recent banking turmoil caused by high-profile bank failures, renewed recession fears, and uncertainty over the Fed’s next move have significantly affected investor sentiment. Amid an uncertain market backdrop, it could be wise to buy and hold fundamentally sound, dividend-paying stocks Oracle Corporation (ORCL), CVS Health (CVS), and Humana (HUM)…

The stock market will likely stay under pressure this year, with stubborn inflation and elevated interest rates. However, the Fed’s decision could largely be influenced by concerns about the recent banking crisis. Amid such uncertainty, fundamentally sound stocks Johnson & Johnson (JNJ), Abbott Laboratories (ABT), and Humana (HUM) could be…

Investor sentiment has been significantly affected due to the recent bank failures and concerns over the Fed’s forthcoming rate hike. With the end to the current market volatility not in sight, investors may consider buying fundamentally strong stocks, The Coca-Cola Company (KO), Oracle (ORCL), Humana (HUM), and Gartner (IT), to…

As the Fed is expected to raise interest rates higher than expected, the revived recession fears will keep the stock market under pressure in the upcoming months. Thus, it could be wise to scoop up shares of high-quality businesses, such as Johnson & Johnson (JNJ), Humana Inc. (HUM), and AutoZone,…

Amid concerns that sticky inflation might lead to more rate hikes, the stock market is expected to remain volatile in the near term. So, investors should focus on their long-term strategy and scoop up quality stocks McDonald's (MCD), Verizon (VZ), Salesforce (CRM), Humana (HUM), and STMicroelectronics (STM), which look poised…

Humana earnings topped Q4 estimates. The top-rated managed care stock gave positive 2023 guidance. HUM stock flirted with a buy signal.

With expanding medical needs and technological advancements, the healthcare industry’s prospects look impressive. Moreover, healthcare stocks tend to perform relatively well, irrespective of economic conditions, thanks to the inelastic demand for their products and services. Therefore, we think Nature’s Sunshine Products (NATR), Abbott Laboratories (ABT), Humana (HUM), Molina Healthcare (MOH),…

With economic growth moderating just enough to keep hopes of a Fed-engineered ‘soft landing’ alive, shares of fundamentally strong, resilient, and growing businesses AT&T (T), Amgen (AMGN), Humana (HUM) could be worth investing in for sustained risk-adjusted returns. Continue reading….